<i>In vitro</i> to <i>in vivo</i> extrapolation to support the development of the next generation risk assessment (NGRA) strategy for nanomaterials-Reference-Cited by-同舟云学术

In vitro to in vivo extrapolation to support the development of the next generation risk assessment (NGRA) strategy for nanomaterials

Published:2022 Issue:18 Volume:14 Page:6735-6742
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Jagiello Karolina¹²^ORCID,Ciura Krzesimir¹³

Affiliation:

1. QSAR Lab Ltd., Trzy Lipy 3, 80-172 Gdansk, Poland

2. University of Gdansk, Faculty of Chemistry, Wita Stwosza 63, 80-308 Gdansk, Poland

3. Medical University of Gdansk, Faculty of Pharmacy, Department of Physical Chemistry, J. Hallera Avenue 107, 80-416, Gdansk, Poland

Abstract

The in vitro to in vivo extrapolation models (IVIVE) can support the development of the Next Generation Risk Assessment through integration the AOP-anchored strategy for in vitro assays selection with the PBPK models.

Funder

H2020 Health

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/NR/D2NR00664B

Reference43 articles.

1. Biotransformation in vitro: An essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data

2. Quantitativein vitrotoin vivoextrapolation of cell-based toxicity assay results

3. Regulatory use and acceptance of alternative methods for chemical hazard identification

4. J.Bessems , S.Coecke , V.Gouliarmou , M.Whelan and A.Worth , EURL ECVAM Strategy for Achieving 3Rs Impact in the Assessment of Toxicokinetics and Systemic Toxicity , Publications Office of the European Union , 2015 , p. JRC96418

5. Principles underpinning the use of new methodologies in the risk assessment of cosmetic ingredients

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting zeta potential of liposomes from their structure: A nano-QSPR model for DOPE, DC-Chol, DOTAP, and EPC formulations;Computational and Structural Biotechnology Journal;2024-12

2. Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers;Advanced Materials;2024-09-10

3. Current Challenges to Align Inflammatory Key Events in Animals and Lung Cell Models In Vitro;Chemical Research in Toxicology;2024-08-08

4. Overview of in vitro-in vivo extrapolation approaches for the risk assessment of nanomaterial toxicity;NanoImpact;2024-07

5. Advancing Toxicity Predictions: A Review on in Vitro to in Vivo Extrapolation in Next-Generation Risk Assessment;Environment & Health;2024-05-09